Michael W. Wolff

4.6k total citations
136 papers, 3.3k citations indexed

About

Michael W. Wolff is a scholar working on Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael W. Wolff has authored 136 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 29 papers in Genetics and 25 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael W. Wolff's work include Virus-based gene therapy research (29 papers), Viral Infectious Diseases and Gene Expression in Insects (25 papers) and Monoclonal and Polyclonal Antibodies Research (24 papers). Michael W. Wolff is often cited by papers focused on Virus-based gene therapy research (29 papers), Viral Infectious Diseases and Gene Expression in Insects (25 papers) and Monoclonal and Polyclonal Antibodies Research (24 papers). Michael W. Wolff collaborates with scholars based in Germany, United States and United Kingdom. Michael W. Wolff's co-authors include Udo Reichl, Ralf Heilker, Dieter Bohn, Marcus Fehr, Sylvie Lalonde, Ida Lager, Wolf B. Frommer, Karin M. Danzer, Gerald Birk and Bastian Hengerer and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Applied Physics.

In The Last Decade

Michael W. Wolff

131 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael W. Wolff Germany 31 1.7k 442 379 345 311 136 3.3k
Peng Zou China 37 2.4k 1.4× 159 0.4× 582 1.5× 296 0.9× 215 0.7× 147 4.9k
Kazunori Kawasaki Japan 27 1.4k 0.8× 182 0.4× 197 0.5× 229 0.7× 77 0.2× 140 2.7k
Huaying Zhao United States 32 2.8k 1.6× 289 0.7× 223 0.6× 378 1.1× 116 0.4× 100 4.1k
Ichio Shimada Japan 45 4.8k 2.8× 377 0.9× 82 0.2× 953 2.8× 214 0.7× 253 6.5k
Kai Zhang China 29 3.1k 1.8× 582 1.3× 415 1.1× 230 0.7× 45 0.1× 131 5.3k
Iwan A.T. Schaap Germany 28 1.8k 1.0× 334 0.8× 310 0.8× 48 0.1× 97 0.3× 49 3.6k
Masaaki Matsushima Japan 27 2.1k 1.2× 226 0.5× 159 0.4× 451 1.3× 30 0.1× 139 3.4k
Keith Pardee Canada 24 2.8k 1.6× 337 0.8× 472 1.2× 155 0.4× 82 0.3× 37 3.7k
Xueming Li China 38 4.2k 2.4× 487 1.1× 316 0.8× 117 0.3× 278 0.9× 100 7.0k

Countries citing papers authored by Michael W. Wolff

Since Specialization
Citations

This map shows the geographic impact of Michael W. Wolff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Wolff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Wolff more than expected).

Fields of papers citing papers by Michael W. Wolff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Wolff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Wolff. The network helps show where Michael W. Wolff may publish in the future.

Co-authorship network of co-authors of Michael W. Wolff

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Wolff. A scholar is included among the top collaborators of Michael W. Wolff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Wolff. Michael W. Wolff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amann, Ralf, et al.. (2023). Stability studies for the identification of critical process parameters for a pharmaceutical production of the Orf virus. Vaccine. 41(32). 4731–4742. 5 indexed citations
2.
Wolff, Michael W., et al.. (2023). Optimization and validation of analytical affinity chromatography for the in-process monitoring and quantification of peptides containing a C-tag. Journal of Chromatography B. 1229. 123899–123899. 2 indexed citations
3.
Wolff, Michael W., et al.. (2023). Process intensification for the production of a C-tagged antimicrobial peptide in Escherichia coli – First steps toward a platform technology. Journal of Bioscience and Bioengineering. 136(5). 358–365.
4.
Wolff, Michael W., et al.. (2023). Affinity and Pseudo-Affinity Membrane Chromatography for Viral Vector and Vaccine Purifications: A Review. Membranes. 13(9). 770–770. 13 indexed citations
5.
Fraser, Keith, et al.. (2022). The diverse role of heparan sulfate and other GAGs in SARS-CoV-2 infections and therapeutics. Carbohydrate Polymers. 299. 120167–120167. 14 indexed citations
6.
Marichal‐Gallardo, Pavel, Kathleen Börner, Michael Pieler, et al.. (2021). Single-Use Capture Purification of Adeno-Associated Viral Gene Transfer Vectors by Membrane-Based Steric Exclusion Chromatography. Human Gene Therapy. 32(17-18). 959–974. 33 indexed citations
7.
Wolff, Michael W., et al.. (2020). Production of Baculovirus and Stem Cells for Baculovirus-Mediated Gene Transfer into Human Mesenchymal Stem Cells. Methods in molecular biology. 2183. 367–390. 2 indexed citations
8.
Wolff, Michael W., et al.. (2014). Phenotypic Analysis of Chemokine-Driven Actin Reorganization in Primary Human Neutrophils. Assay and Drug Development Technologies. 12(2). 120–128. 4 indexed citations
9.
Schmidt, Darby, Subharekha Raghavan, Hong C. Shen, et al.. (2010). Anthranilic acid replacements in a niacin receptor agonist. Bioorganic & Medicinal Chemistry Letters. 20(11). 3426–3430. 17 indexed citations
10.
Wolff, Michael W., Jörg Wiedenmann, Barbara Moepps, et al.. (2009). CXCR2 Inverse Agonism Detected by Arrestin Redistribution. SLAS DISCOVERY. 14(9). 1076–1091. 3 indexed citations
11.
Woodruff, Prescott G., Michael W. Wolff, Jens M. Hohlfeld, et al.. (2009). Safety and Efficacy of an Inhaled Epidermal Growth Factor Receptor Inhibitor (BIBW 2948 BS) in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 181(5). 438–445. 63 indexed citations
12.
Wolff, Michael W., et al.. (2009). Capturing of cell culture‐derived modified Vaccinia Ankara virus by ion exchange and pseudo‐affinity membrane adsorbers. Biotechnology and Bioengineering. 105(4). 761–769. 19 indexed citations
13.
Danzer, Karin M., et al.. (2009). Seeding induced by α‐synuclein oligomers provides evidence for spreading of α‐synuclein pathology. Journal of Neurochemistry. 111(1). 192–203. 231 indexed citations
14.
Oswald, Franz, Karin Nienhaus, Karen Deuschle, et al.. (2009). mRuby, a Bright Monomeric Red Fluorescent Protein for Labeling of Subcellular Structures. PLoS ONE. 4(2). e4391–e4391. 173 indexed citations
15.
Nienhaus, Karin, Franz Oswald, Michael W. Wolff, et al.. (2008). Optimized and Far-Red-Emitting Variants of Fluorescent Protein eqFP611. Chemistry & Biology. 15(3). 224–233. 60 indexed citations
16.
Wolff, Michael W., et al.. (2007). Modelling of carbon diffusion and ferritic phase transformations in an unalloyed hypoeutectoid steel. Archives of Mechanics. 59. 435–466. 2 indexed citations
17.
Salaklang, Jatuporn, et al.. (2006). Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses. Vaccine. 25(5). 939–947. 58 indexed citations
18.
Wolff, Michael W., Joerg Wiedenmann, G. Ulrich Nienhaus, Martin J. Valler, & Ralf Heilker. (2006). Novel fluorescent proteins for high-content screening. Drug Discovery Today. 11(23-24). 1054–1060. 34 indexed citations
19.
Haasen, Dorothea, Michael W. Wolff, Martin J. Valler, & Ralf Heilker. (2005). Comparison of G-Protein Coupled Receptor Desensitization-Related β- Arrestin Redistribution Using Confocal and Non-Confocal Imaging. Combinatorial Chemistry & High Throughput Screening. 9(1). 37–47. 17 indexed citations
20.
Wolff, Michael W., et al.. (1998). A Rapid Prototyping Environment for the Concurrent Development of Mechatronic Systems. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peng Zou Breakdown of academic impact, for papers by Kazunori Kawasaki Breakdown of academic impact, for papers by Huaying Zhao Breakdown of academic impact, for papers by Ichio Shimada Breakdown of academic impact, for papers by Kai Zhang Breakdown of academic impact, for papers by Iwan A.T. Schaap Breakdown of academic impact, for papers by Masaaki Matsushima Breakdown of academic impact, for papers by Keith Pardee Breakdown of academic impact, for papers by Xueming Li
Rankless by CCL
2026